NCT04961450Enrolling by invitation
Explore Biomarkers of Motor Neuron Disease/Frontal Dementia Spectrum Disease in China
A Study on the Biomarkers of Motor Neuron Disease/Frontal Dementia Spectrum Disease in China
Source: ClinicalTrials.gov · Last updated 14 Jul 2021 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
1. To investigate the biomarkers of MND/FTD spectrum disease 2. To explore the possible pathogenesis of MND/FTD
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 2500 (estimated)
- First submitted
- 24 Jun 2021
- Start date
- 24 Jun 2021
- Primary completion date
- 31 Dec 2030
- Lead sponsor
- Peking University Third Hospital
- NCT number
- NCT04961450
What you commit to
- Study type: Observational
- Planned participants: 2500
- From 24 Jun 2021 to the primary completion date, 31 Dec 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Suffering from neurological disease, including but not limited to motor neuron disease/frontotemporal dementia spectrum disease, dementia, Alzheimer's disease, Parkinson's disease, multiple sclerosis, neuromyelitis and so on.
Other
- Individuals who refuse to sign informed consent.
Who the study is looking for
- Patients aged 18-80 years who visit Peking University Third Hospital, Beijing, China from December 2020.
- Patients who diagnosis MND/FTD spectrum disease (including ALS, FAS, FLS, PLS, PBP, PMA, FTD, MND-FTD) by an experienced neurologist strictly according to a list of diagnosis criteria and clinical guidelines
- Informed consent signed Exclusion Criteria
- Patients who receive alternative diagnoses during the follow-up.
- Patients who refuse to sign informed consent.
- Control group:
- Control group consists of individuals matched for gender and age with the patients who are mainly the caregivers of the patients, including but not limited to the patients' spouses and their long-term nurses.
Criteria the registry did not label
- Patients:
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dongsheng Fan Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.